Johannes Heinrich Bartholomaeus

Title: Innovations and Contributions of Johannes Heinrich Bartholomaeus in Pharmaceutical Patents

Introduction

Johannes Heinrich Bartholomaeus, an accomplished inventor from Aachen, Germany, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 26 patents, his innovative work focuses on the development of advanced pharmaceutical formulations aimed at improving drug delivery and effectiveness.

Latest Patents

Some of his latest patented inventions include a prolonged release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol. This formulation is designed to provide a controlled release of the active ingredient, enhancing its therapeutic efficacy over time. The detailed release profile of this formulation includes specific percentages of the active ingredient released at various intervals, making it a valuable advancement in pharmaceutical sciences. Additionally, he has developed an abuse-proof dosage form, which utilizes a viscosity-increasing agent to protect against parenteral abuse. This innovative solid administration form significantly enhances patient safety while maintaining drug efficacy.

Career Highlights

Throughout his career, Johannes has worked with notable companies, including Grünenthal GmbH, contributing to the research and development of various pharmaceutical products. His dedication to innovation has led to significant advancements in drug formulation and delivery methods, establishing him as a leading inventor in the pharmaceutical industry.

Collaborations

Bartholomaeus has collaborated with skilled professionals, such as Iris Ziegler and Heinrich Kugelmann. These partnerships have facilitated knowledge exchange and have contributed to the successful development of his patented inventions, showcasing the importance of teamwork in driving innovation.

Conclusion

Johannes Heinrich Bartholomaeus stands out as a visionary inventor whose work continues to influence the pharmaceutical field. His commitment to developing safe and effective drug delivery systems has not only advanced medical science but also highlighted the critical role of innovation in improving patient care. As he continues to contribute to the industry, his patents serve as a testament to the dynamic and evolving nature of pharmaceutical research and development.